These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 160889)

  • 1. Comparison of natural killer cells induced by Kunjin virus and Corynebacterium parvum with those occurring naturally in nude mice.
    Macfarlan RI; Ceredig R; White DO
    Infect Immun; 1979 Dec; 26(3):832-6. PubMed ID: 160889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.
    Hassan ZM; Rees RC; Potter CW
    Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii.
    Luft BJ; Remington JS
    J Immunol; 1984 May; 132(5):2375-80. PubMed ID: 6715884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro augmentation of rat natural killer (NK) cell activity.
    Reynolds CW; Herberman RB
    J Immunol; 1981 Apr; 126(4):1581-5. PubMed ID: 6451648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempts to correlate interferon induction and activation of natural killer cells by Corynebacterium parvum.
    Chmielarczyk W; Kirchner H; Ernst R; Storch E
    Immunobiology; 1985 May; 169(4):403-11. PubMed ID: 2408996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
    Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
    Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of NK activity by Corynebacterium parvum fractions in vivo and in vitro.
    Lichtenstein A; Bick A; Cantrell J; Zighelboim J
    Int J Immunopharmacol; 1983; 5(2):137-44. PubMed ID: 6874167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two anti-tumour cytotoxic cells in the peritoneal cavity of rats: natural occurrence, augmentation and partial characterization.
    Inoue Y; Nelson DS
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):41-53. PubMed ID: 7092732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice: natural killer cell activity in cultured spleen leukocytes concomitant with T-cell-dependent immune interferon production.
    Welsh RM; Doe WF
    Infect Immun; 1980 Nov; 30(2):473-83. PubMed ID: 6160108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-tumour cytostatic and cytotoxic properties of peritoneal exudate cells of conventional and germ-free mice, stimulated or not by "Corynebacterium parvum" (author's transl)].
    Fray A; Moreau C; Thobie N; Ducluzeau R
    Ann Immunol (Paris); 1982; 133C(1):33-43. PubMed ID: 7092174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in-vitro antitumor activity of peritoneal cells from mice injected with Corynebacterium parvum and Corynebacterium liquefaciens.
    Toge T; Hattori T
    Hiroshima J Med Sci; 1979 Jun; 28(2):95-101. PubMed ID: 478988
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer cells in leukemogenesis.
    Seidel HJ; Stolz W; Sutter H; Kreja L
    Leuk Res; 1986; 10(7):803-8. PubMed ID: 3736113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer inhibitory substance produced by the peritoneal cells of patients with ovarian cancer.
    Lichtenstein AK; Berek J; Zighelboim J
    J Natl Cancer Inst; 1985 Feb; 74(2):349-55. PubMed ID: 3856049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum.
    Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim J
    J Biol Response Mod; 1984 Aug; 3(4):371-8. PubMed ID: 6541243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.